Somatogen (SMTG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kha vu who wrote (239)	8/5/1997 10:50:00 AM
From: Ford Investor	of 442

I just happened to get off the phone with my broker and he recommended getting into SMTG because it is ready for a huge runup. The reason why Eli Lilly pulled out from negotiations is that they wanted to much of a piece of the worldwide pie. Currently, they are conducting Phase II testing at the FDA which is planned to be completed by October 1997, Phase III begins and usually takes about a year which places the approval at approximately October 1998. Also, it takes about a year to market the product worldwide which places the rollout of the blood substitute by October 1999. Investors are betting that they cannot come out with the product before the year 2000. Somatogen currently has enough cash to be able to survive for 3 years. The company does not want to be in a position where it is barely getting by, so plans are probably in the works of them teaming up with someone in the future. My broker sees this company at $15 by October 1997 and even higher in the future. This revolutionary product will revoltionize the medical history. As you have seen, the directors are buying shares in the company which means that he has confidence in the stock for the long term. Gentlemen, it is time to get in before it is too late! Good Luck To All! :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next